Repurposing Bromocriptine for Abeta Metabolism in Alzheimer's Disease

Condition:   Alzheimer's Disease With PSEN1 Mutations Interventions:   Drug: Bromocriptine;   Drug: Placebos Sponsors:   Kyoto University;   Mie University;   Osaka University;   Tokushima University;   Tokyo Metropolitan Geriatric Medical Center;   Asakayama General Hospital;   Kawasaki Medical School Hospital;   Time Therapeutics, Inc.;   Towa Pharmaceutical Co.,Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials